- Home
- OESX vs CLNN Comparison
OESX vs CLNN Comparison
Compare OESX & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OESX | CLNN |
|---|---|---|
| Founded | 1996 | 2012 |
| Country | United States | United States |
| Employees | N/A | 79 |
| Industry | Building Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.7M | 60.3M |
| IPO Year | 2007 | N/A |
Fundamental Metrics
Financial Performance| Metric | OESX | CLNN |
|---|---|---|
| Price | $9.25 | $5.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | $17.50 | ★ $32.67 |
| AVG Volume (30 Days) | 28.8K | ★ 77.6K |
| Earning Date | 02-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $79,720,000.00 | N/A |
| Revenue This Year | $7.94 | $12.20 |
| Revenue Next Year | $13.89 | $20,465.06 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.55 | $2.28 |
| 52 Week High | $18.64 | $13.50 |
Technical Indicators
Market Signals| Indicator | OESX | CLNN |
|---|---|---|
| Relative Strength Index (RSI) | 37.30 | 47.40 |
| Support Level | $9.02 | $3.54 |
| Resistance Level | $10.17 | $6.83 |
| Average True Range (ATR) | 0.71 | 0.62 |
| MACD | 0.11 | -0.11 |
| Stochastic Oscillator | 22.57 | 29.26 |
Price Performance
Historical ComparisonAbout OESX Orion Energy Systems Inc.
Orion Energy Systems Inc is engaged in light-emitting diode lighting systems, wireless Internet of Things-enabled control solutions, project engineering, energy project management design, maintenance services, and turnkey electric vehicle charging stations and related installation services to commercial and industrial businesses, and federal and local governments, predominantly in North America. The group has three segments: the Orion lighting segment, the Orion maintenance segment, and the Orion electric vehicle charging segment. It generates the majority of its revenue from the Orion lighting segment, which develops and sells lighting products and provides construction and engineering services for Orion's commercial lighting and energy management systems.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.